News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Oscar Tahuahua: Advances in Molecular Pathology and Therapy of NSCLC
Oscar Tahuahua/X
Jun 16, 2025, 11:26

Oscar Tahuahua: Advances in Molecular Pathology and Therapy of NSCLC

Oscar Tahuahua, Medical Oncology fellow at the National Cancer Institute of Mexico, shared a post on X:

“Advances in Molecular Pathology and Therapy of NSCLC.
Precision oncology is no longer optional. This review maps the molecular landscape of NSCLC (EGFR, ALK, KRAS, etc.), resistance, spatial omics and AI, and shows how biology is reshaping lung cancer treatment.
Resistance in NSCLC isn’t accidental, it’s adaptive. This explains how EGFR T790M, KRAS/STK11, EMT and an immunosuppressive TME reshape tumor biology under treatment pressure.”

Title: Advances in molecular pathology and therapy of non-smallcell lung cancer

Authors: Qing Huang, Yuanxiang Li, Yingdan Huang, Jingyi Wu, Wendai Bao, Chang Xue, Xiaoyu Li, Shuang Dong, Zhiqiang Dong, Sheng Hu

Read The Full Article at Signal Transduction and Targeted Therapy.

Oscar Tahuahua: Advances in Molecular Pathology and Therapy of NSCLC

More posts featuring Oscar Tahuahua on OncoDaily.

cancer Chang Xue Jingyi Wu lung cancer treatment NSCLC OncoDaily Oncology Oscar Tahuahua Precision Oncology Qing Huang Sheng Hu Shuang Dong Wendai Bao Xiaoyu Li Yingdan Huang Yuanxiang Li Zhiqiang Dong
Special Coverage
Blog
Jul 19, 2025, 02:39
Alisher Kakharov: Training at the Prestigious Saint-Louis Hospital in Paris
Blog
Jul 19, 2025, 02:07
Bernard A. Fox: Back in Taiwan - Sharing the Next Frontier in Cancer Immunotherapy at Grand Rounds
Blog
Jul 19, 2025, 02:00
Akash Maniam: How Best to De-Escalate Excellent Responders and Intensify Those Who Don't
Insight
Jul 18, 2025, 21:36
Major disparities in access to Molecular Tumour Boards - Lung Cancer Europe
Oncolibrary
Jul 18, 2025, 21:35
Top 5 AI Tools for Medical Oncologists
Blog
Jul 18, 2025, 20:11
From Lab to Stage: Mastering Research Presentations as a PhD student - Manchester Cancer Research Centre
Blog
Jul 18, 2025, 19:49
Final Call for Discounted Registration to IASLC 2025 World Conference on Lung Cancer
Science
Jul 18, 2025, 19:26
Alfredo Addeo: A True Game Changer in Targeted Therapy for Lung Cancer
Blog
Jul 18, 2025, 19:23
Above and Beyond Awards ceremony at The Institute of Cancer Research
Blog
Jul 18, 2025, 19:04
"Belantamab Mafodotin Gives Patients a Chance," Says Diane Moran - International Myeloma Foundation
Insight
Jul 18, 2025, 18:53
Raffaele Colombo: International Nonproprietary Names Proposed List 133 Is Out
Insight
Jul 18, 2025, 18:46
Akhil Santhosh: OrigAMI1 - The Effect of Amivantamab in Previously Treated RAS Wild Colon Cancer